Changed distribution pattern of the constitutive rather than the inducible HSP70 chaperone in neuromelanin-containing neurones of the Parkinsonian midbrain

被引:14
作者
Andringa, G
Bol, JGJM
Wang, X
Boekel, A
Bennett, MC
Chase, TN
Drukarch, B
机构
[1] Vrije Univ Amsterdam Med Ctr, ICEN, Dept Med Pharmacol, NL-1081 BT Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, ICEN, Dept Anat, NL-1081 BT Amsterdam, Netherlands
[3] Natl Inst Neurol Disorders & Stroke, Expt Therapeut Branch, NIH, Bethesda, MD 20892 USA
关键词
heat shock protein 70; immunohistochemistry; Lewy body; neuromelanin; neuroprotection; Parkinson's disease;
D O I
10.1111/j.1365-2990.2006.00714.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aberrant protein aggregation has been recognized as an important factor in the degeneration of melanized dopaminergic neurones in Parkinson's disease (PD). The constitutive (HSP73) and (heat)-inducible (HSP72) proteins of the heat shock 70 family form a major defence system against pathological protein aggregation. However, the distribution patterns of these chaperones in nigral neuromelanin-laden neurones are largely unknown. The present study determined the distribution of HSP72 and HSP73 in control and Parkinsonian substantia nigra, using immunohistochemistry. In the neuromelanin-laden neurones of controls, HSP72 was nondetectable, whereas HSP73 was weakly expressed in both the cytosol and the nucleus. Surprisingly, in PD subjects, marked nuclear HSP73, but not HSP72 immunoreactivity was observed, while cytosolic immunoreactivity of the two chaperones resembled the labelling pattern observed in controls. Furthermore, HSP73 immunoreactivity was observed in a subset of the Lewy bodies (LBs) detected in the substantia nigra of PD subjects, whereas only few of these LBs were labelled with HSP72. Interestingly, HSP72 and to a lesser extent HSP73 immunoreactivity was much stronger in nonmelanized neurones as compared with melanized neurones in this area. Thus, we conclude that the distribution pattern of HSP73 rather than HSP72 is changed in the nigral neuromelanin-laden neurones of PD subjects as compared with control subjects. The impaired ability of aged, dopaminergic neurones to express high levels of chaperones, may contribute to the preferential vulnerability of the latter cells in PD.
引用
收藏
页码:157 / 169
页数:13
相关论文
共 45 条
  • [1] POSSIBLE CORRELATION BETWEEN DNA-DAMAGE INDUCED BY HYDROGEN-PEROXIDE AND TRANSLOCATION OF HEAT-SHOCK-70 PROTEIN INTO THE NUCLEUS
    ABE, T
    KONISHI, T
    HIRANO, T
    KASAI, H
    SHIMIZU, K
    KASHIMURA, M
    HIGASHI, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (02) : 548 - 555
  • [2] Redox regulation of mammalian heat shock factor 1 is essential for Hsp gene activation and protection from stress
    Ahn, SG
    Thiele, DJ
    [J]. GENES & DEVELOPMENT, 2003, 17 (04) : 516 - 528
  • [3] Tissue trans glutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease
    Andringa, G
    Lam, KY
    Chegary, M
    Wang, X
    Chase, TN
    Bennett, MC
    [J]. FASEB JOURNAL, 2004, 18 (03) : 932 - +
  • [4] Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease
    Auluck, PK
    Chan, HYE
    Trojanowski, JQ
    Lee, VMY
    Bonini, NM
    [J]. SCIENCE, 2002, 295 (5556) : 865 - 868
  • [5] Bercovich B, 1997, J BIOL CHEM, V272, P9002
  • [6] Staging of brain pathology related to sporadic Parkinson's disease
    Braak, H
    Del Tredici, K
    Rüb, U
    de Vos, RAI
    Steur, ENHJ
    Braak, E
    [J]. NEUROBIOLOGY OF AGING, 2003, 24 (02) : 197 - 211
  • [7] The Hsp70 and Hsp60 chaperone machines
    Bukau, B
    Horwich, AL
    [J]. CELL, 1998, 92 (03) : 351 - 366
  • [8] Regional distribution of heme oxygenase, HSP70, and glutathione in brain: Relevance for endogenous oxidant/antioxidant balance and stress tolerance
    Calabrese, V
    Scapagnini, G
    Ravagna, A
    Fariello, RG
    Stella, AMG
    Abraham, NG
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 68 (01) : 65 - 75
  • [9] Molecular chaperones in protein folding and translocation
    Clarke, AR
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 1996, 6 (01) : 43 - 50
  • [10] Drug treatment of Parkinson's disease - Time for phase II
    Drukarch, B
    van Muiswinkel, FL
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 59 (09) : 1023 - 1031